Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Streptococcus Pyogenes</i> and Acute Rheumatic Fever: How Strong are the Links in the Chain?

Global heart·2026
Same author

Right aortic arch and double arch assessed by prenatal echocardiography: a population-based study.

European heart journal·2026
Same author

Impact of Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease Over 5 Years.

Journal of the American Heart Association·2026
Same author

Feasibility and Acceptability of a Breastfeeding Support Intervention Among Mothers of Infants Under Six Months Old Discharged From Malnutrition Treatment in Kilifi County.

Maternal & child nutrition·2026
Same author

Comparative evaluation of performance and precision of multiplex immunoassays measuring human IgG to <i>Streptococcus pyogenes</i> vaccine antigens.

Frontiers in immunology·2026
Same author

Ivermectin to Control Malaria - A Cluster-Randomized Trial.

The New England journal of medicine·2026

Related Experiment Video

Updated: Dec 30, 2025

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
07:14

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Published on: July 11, 2025

472

A Roadmap for the Development of Ivermectin as a Complementary Malaria Vector Control Tool.

1, Peter Billingsley2, Fred Binka3

  • 1Full List of Contributors in the Acknowledgments.

The American Journal of Tropical Medicine and Hygiene
|January 24, 2020
PubMed
Summary

Mass drug administration of ivermectin shows promise for malaria control by reducing mosquito lifespan. This roadmap outlines steps for its community-level deployment against insecticide-resistant mosquitoes and residual transmission.

More Related Videos

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
05:28

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Published on: May 12, 2022

3.5K
Microinjection Method for Anopheles gambiae Embryos
05:39

Microinjection Method for Anopheles gambiae Embryos

Published on: July 7, 2021

5.3K

Related Experiment Videos

Last Updated: Dec 30, 2025

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
07:14

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Published on: July 11, 2025

472
Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
05:28

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Published on: May 12, 2022

3.5K
Microinjection Method for Anopheles gambiae Embryos
05:39

Microinjection Method for Anopheles gambiae Embryos

Published on: July 7, 2021

5.3K

Area of Science:

  • Global Health
  • Vector-Borne Disease Control
  • Malariology

Background:

  • Insecticide resistance and residual malaria transmission necessitate novel control strategies.
  • Ivermectin, an endectocide, demonstrates potential as a complementary vector control tool.
  • The World Health Organization (WHO) has established preferred product characteristics for endectocides in vector control.

Framework:

  • A roadmap details processes for ivermectin's integration as a vector control agent by 2024.
  • Key considerations include optimal dosage for humans and livestock, and resistance risk assessment.
  • Ethical, political, community engagement, and policy translation are crucial for deployment.

Implementation:

  • Large-scale deployment strategies for ivermectin as a community-level preventive tool are addressed.
  • Operational aspects of mass drug administration (MDA) are outlined.
  • Multidisciplinary global health experts contributed to this strategic roadmap.

Implications:

  • Ivermectin offers a novel mechanism of action to combat malaria.
  • Successful implementation can counteract insecticide resistance and residual transmission.
  • This initiative aims to contribute to the global eradication of malaria.